Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

od Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Izdano u Cancer Sci (2019)

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes

od Jiang, Lingxu, Wang, Lu, Shen, Chuying, Zhu, Shuanghong, Lang, Wei, Luo, Yingwan, Zhang, Hua, Yang, Wenli, Han, Yueyuan, Ma, Liya, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Izdano u Am J Cancer Res (2020)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

od Lin, Peipei, Ren, Yanling, Yan, Xiaomei, Luo, Yingwan, Zhang, Hua, Kesarwani, Meenu, Bu, Jiachen, Zhan, Di, Zhou, Yile, Tang, Yuting, Zhu, Shuanghong, Xu, Weilai, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Li, Hu, Chao, Azam, Mohammad, Ding, Wei, Jin, Jie, Huang, Gang, Tong, Hongyan
Izdano u Haematologica (2019)